Microbot Medical Inc. to Present at the Thirteenth Annual Noble Capital Markets Investor Conference

HINGHAM, Mass., Jan. 23, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, announced today that Harel Gadot, Chief Executive Officer, President, and Chairman of Microbot Medical and Hezi Himelfarb, General Manager and Chief Operating Officer of Microbot Medical will present at the Thirteenth Annual Noble Capital Markets Investor Conference at the Boca Raton Resort & Club in Boca Raton, Florida, on Monday, January 30th at 3:30 pm ET.

A high-definition, video webcast of the Company’s presentation will be available via this link: http://noble.mediasite.com/mediasite/Play/32fb3f65f72b45db937547ed5f2f9a9d1d or on the Presentations & Resources page of the Investor section of the Company’s website www.microbotmedical.com. The webcast and presentation will be archived on the Company's website for 90 days following the event.

About Microbot Medical, Inc.

Microbot was founded in 2010 and became a NASDAQ listed company on November 28, 2016. The Company specializes in transformational micro-robotic medical technologies leveraging the natural and artificial lumens within the human body. Microbot’s current platforms, ViRob and TipCAT, are comprised of two highly advanced micro-robotic technologies, from which the Company is currently developing its first two product candidates: the Self Cleaning Shunt, or SCS, for the treatment of hydrocephalus and Normal Pressure Hydrocephalus, or NPH; and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. Further information about Microbot Medical is available at http://www.microbotmedical.com.

The ViRob technology is a revolutionary autonomous crawling micro-robot which can be controlled remotely or within the body.  Its miniature dimensions allow it to navigate and crawl in different spaces within the human body, including blood vessels, the digestive tract and the respiratory system.  Its unique structure gives it the ability to move in tight spaces and curved passages as well as the ability to remain within the human body for prolonged time.  To learn more about ViRob please visit http://www.microbotmedical.com/technology/virob/.

TipCAT is a transformational self-propelled, flexible, and semi-disposable endoscope providing see & treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract.  Its locomotion mechanism is perfectly suitable to navigate and crawl through natural & artificial tubular lumens, applying the minimal necessary pressure to achieve the adequate friction required for gentle, fast, and safe advancement within the human body.  To learn more about TipCAT visit http://www.microbotmedical.com/technology/tipcat/.

Investor Contacts:

EVC Group                              
Michael Polyviou/Doug Sherk - Investors                                             
[email protected]; [email protected]  
212-850-6020; 415-652-9100